Form 483

Sincerus Florida, LLC dba SKNV Form 483, 2018-09-17

FDA issued a Form 483 to Sincerus Florida, LLC dba SKNV on 2018-09-17 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Sincerus Florida, LLC dba SKNV · Pompano Beach, United States · Issued September 17, 2018

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Sep 2018
21 CFR 211.110(a)(3)

Mixing adequacy

Cited by Jennifer L Huntington, June P Page

17 Sep 2018
21 CFR 211.165(a)

Testing and release for distribution

Cited by Jennifer L Huntington, June P Page

17 Sep 2018
21 CFR 211.166(a)

Lack of written stability program

Cited by Jennifer L Huntington, June P Page

17 Sep 2018
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jennifer L Huntington, June P Page

17 Sep 2018
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Jennifer L Huntington, June P Page

Inspected site

SFSincerus Florida, LLC dba SKNVPompano Beach, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere